C12N 2770/34033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2770/34033 (Use of viral protein as therapeutic agent other than vaccine) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 4
- Inventors
- 4
- Latest grant
- 4 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Selective cell death-inducing enzyme system24 Nov 2022US 2022/0370555 A1SIT Biotech GmbH
- Selective cell-death-inducing binary enzyme system11 Apr 2019US 2019/0105378 A1SIT - SOFT INTELLIGENT THERAPEUTICS GMBH & CO. KG (Claus Simandi)
- Selective cell-death-inducing binary enzyme system11 Feb 2016US 2016/0038573 A1SIT-Soft Intelligent Therapeutics GmbH & Co. KG
- Amyloid-beta clearance2 May 2013US 2013/0108613 A1Gwangju Institute of Science and Technology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.